AIC T-Hub launches 5th cohort of healthcare programme

T-Hub, in collaboration with Atal Innovation Mission (AIM) has announced the launch of the 5th cohort of AIC T-Hub Healthcare Program. The program has selected 20 startups from a competitive pool of over 209 applications.

This three-month hybrid program is designed to accelerate innovation in MedTech, digital health, and healthcare accessibility by providing startups with mentorship, market access, investor engagement, and regulatory guidance. Among the selected startups are Artyem Care, Bioscafil, Chqup, Cloud Palliative Care, Dag2IL, Epirelief, Dr. DICOM (GLOCAL DIGITAL), Kashi Medicos, Nahush Pharma, Oui Medical, Planytics, Reyansh Technologies, Sigma Mozak, Signel Biomedical, Skinska, Tap Health, thebabyland, TurocratesAI, 365Veda, and Warkas. These startups were selected based on their proof-of-concept readiness, technological innovation, regulatory compliance preparedness, market potential, and the strength of their founding teams.

Throughout the program, they will gain one-on-one mentorship with industry veterans, strategic introductions to hospitals and corporates, and exclusive investor networking opportunities to help secure funding and business collaborations. Through this program, startups will gain access to hospitals and healthcare institutions for real-world validation and pilot studies, ensuring their solutions are market-ready and clinically viable. They will also receive guidance on navigating domestic and international healthcare regulations, which is critical for scaling in a highly regulated industry.

Additionally, by engaging with venture capitalists, healthcare firms, and policymakers, startups will have opportunities to forge strategic partnerships and secure funding. Market access will be a key focus, with curated introductions to hospitals, corporates, and healthcare organisations that can facilitate the growth and adoption of innovative solutions.

Since its inception, AIC T-Hub has supported 53 healthcare startups across four previous cohorts in MedTech, digital health, and healthcare accessibility. These startups have collectively raised over ₹60.46 crore in funding from investors and grants; facilitated more than 180 market access opportunities with hospitals, corporates, and healthcare institutions; and participated in global healthcare conferences that have significantly boosted their visibility and industry connections. Through initiatives like Doctors & Hospitals Roundtables, startups have been able to showcase their products to key stakeholders, further enabling collaboration and adoption.

Looking ahead, AIC T-Hub aims to strengthen clinical validation opportunities through collaborations with hospitals, research labs, and pharmaceutical companies. The program also aims to onboard one or two international startups to introduce them to India’s healthcare ecosystem, fostering cross-border innovation. Additionally, AIC T-Hub is building a network of doctors, hospitals, and sector-focused investors to support startup success. The program will conclude with a Demo Day and Investor Connect in June 2025, where participating startups will present their solutions to industry leaders and potential investors.